VIGL Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.

$10.81  -0.15 (-1.37%)
As of 02/03/2023 14:41:26 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  01/06/2022
Outstanding shares:  35,581,091
Average volume:  18,900
Market cap:   $378,938,619
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BNHSPZ7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.86
PS ratio:   0.00
Return on equity:   -16.70%
Net income %:   0.00%